T-AYU-HM :: Ayurvedic Physicians are know as VAIDYARAJ. Dr. Atul Desai, Chief Physician of Dhanvantari Clinic & Ayurvedic Health Care Center

The herbomineral formulation T-AYU-HMTM was found to exhibit antidrepanocytary activity in Emmel’s test. At the concentration of 15ug/ml, 30ug/ml and 45ug/ml it showed 44.89%, 49.24% and 60.16% inhibition of sickling of RBC’s.

2. AIM:-
To Evaluate Antidrepanocytary (Anti sickle cell anemia) activity of T-Ayu HTTM, a Herbomineral formulation using Emmel’s test.

3. MATERIALS AND METHODS:-

Herbomineral formulation:-

Test Material:-T AYU-HMTM was supplied by Dr Atul Desai, Dhanvantri clinic, Ayurvedic healthcare centre, Sardar chowk, Vyara, Dist:-Surat, Gujarat (INDIA)

Blood samples:-
Blood samples used for evaluation of the antidrepanocytary activity of the Herbomineral formulation in this study were taken from known drepanocytary adolescent subjects from Dhanvantri clinic, Ayurvrdic Health care centre, sardar chowk, Vyara, Dist:-surat, Gujarat (INDIA).
The samples were stored at +4ºC in refrigerator.

SS BLOOD

SAMPLE NO.	AGE
1	22
2	15
3	25
4	16
5	15
6	26
7	13

Biological activity:
Blood sample was put in contact with the Herbomineral formulation (T AYU-HMTM) at different concentrations prepared using saline (0.9% Sodium chloride), as per Emmel’s test procedure. In brief the method involved the following steps:

The blood samples and the test drug suspension were mixed in equal volumes (v\v).
A drop of treated\untreated blood samples was placed on slide and hermetically covered by cover glass using vaccum grease.
In order to ensure complete anaerobic condition, the slides were placed in vaccum desiccator and incubated at 37˚C for 24 h.
The number of observed erythrocytes was determined using photo microscopy under the magnification of 45X. Photo documentation of was carried out using DTV250 software.

4. RESULTS:-
The antisickling activity of the Herbomineral formulation (T AYU-HMTM) was 44.89%, 49.24%, 61.16% at concentrations of 15 µg/ml, 30 µg/ml, 45 µg/ml respectively

Table no: 01 Effect of T AYU-HMTM on Sickle cell anemia

Blood sample No.	Sickle cells inhibition (%)
	Post treatment Dose concentrations (ug/ml)
	15 ug/ml	30 ug/ml	45 ug/ml
1	28.24	53.86	69.68
2	63.39	65.92	68.67
3	46.95	45.69	74.72
4	18.85	37.5	67.60
5	66.60	64.29	56.44
6	28.57	3.37	12.84
7	61.62	74.07	78.16
Mean % inhibition	44.89	49.24	61.16

The Anti Drepanocytary activity of Herbomineral formulation T AYU-HMTM on blood samples No. 1 to 7 was found to be 50.59%, 65.99%, 55.78%, 41.31%, 61.44%, 14.92% and 71.28% respectively.

Blood sample no 01 showed 4-5% sickle cells before performing Emmels test. Similarly sample no 2, 3, 4, 5, 6 and & showed 6-7%, 4-5%, 3-4%, 6-7%, 2-3%and 8-9% respectively.

Percentage increase in sickle cell count post Emmel’s test in sample no. 2, 5, and 7 was 55%, 56%, and 58% respectively as compared to Blood samples No. 1, 3, 4 and 6 which exhibited 26%, 45%, 26% and 25% respectively (table no. 02). Thus we can say that the patient no 2, 5 and & 7are more susceptible to under go crisis conditions.

Table no: 03 Mean percentage inhibition of sickle cell anemia

SS BLOOD SAMPLE NO.	MEAN % INHIBITION
1	50.59
2	65.99
3	55.78
4	41.31
5	61.44
6	14.92
7	71.28

TABLE 2. Influence of T AYU-HMTM on SS Blood samples using Emmel’s test:-

SS Blood Samle No.	No. of Sickle cells in SS blood sample/100 RBC’s	No. off Sickle cells/100 RBC’s after Emmel’s test (pretreatment to T AYU-HMTM)	Dose (ug/ml)	Sickle cells after Emmel’s test (Post Treatment with T AYU-HMTM)
1	5 4	38 34	30	12
				8
			60	9
				7
			90	4
				6
2	6 7	52 57	30	12
				7
			60	6
				8
			90	12
				7
3	5 4	47 42	30	17
				14
			60	14
				17
			90	7
				9
4	3 4	24 27	30	12
				16
			60	7
				14
			90	4
				3
5	7 6	59 52	30	7
				12
			60	12
				11
			90	7
				6
6	2 3	22 27	30	10
				6
			60	4
				7
			90	5
				7
7	9 8	59 56	30	18
				14
			60	9
				8
			90	7
				6

TABLE 4. Dose dependent inhibition of theHerbomineral formulation T AYU-HM on SS Blood Sample

CONCENTRATION (µg/ml)	% INHIBITION OF SICKLE CELLS
30	44.89
60	49.24
90	61.16

SS BLOOD SAMPLE NO.
	1	2	3	4	5	6	7	MEAN	SD	% INHIBITION
CONTROL	38	52	47	24	59	22	59
	34	57	42	27	52	27	56
MEAN	36	54.5	44.5	25.5	55.5	24.5	57.5	42.57	14.13
SD	2.83	3.54	3.54	2.12	4.95	3.54	2.12

TREATMENT
15 (ug/ml)	26.67	24.00	24.64	17.14	14.00	20.00	25.71
	25.00	15.91	22.58	24.24	23.08	15.00	18.42
MEAN	25.84	19.95	23.61	20.69	18.54	17.50	22.07	21.17	2.90	50.27
SD	1.18	5.72	1.45	5.02	6.42	3.54	5.16
% SICKLE CELL INHIBITION	28.24	63.39	46.95	18.85	66.60	28.57	61.62	44.89


30 (ug/ml)	18.00	17.14	20.00	10.00	20.00	18.18	15.00
	15.22	20.00	28.33	21.88	19.64	29.17	14.81
MEAN	16.61	18.57	24.17	15.94	19.82	23.67	14.91	19.10	3.68	55.14
SD	1.97	2.02	5.89	8.40	0.25	7.77	0.13
% SICKLE CELL INHIBITION	53.86	65.92	45.69	37.5	64.29	3.37	74.07	49.24


45 (ug/ml)	8.50	20.69	10.00	10.00	26.92	20.83	14.00
	13.33	13.46	12.50	6.52	21.43	21.88	11.11
MEAN	10.92	17.08	11.25	8.26	24.18	21.35	12.56	15.08	5.93	64.57
SD	3.42	5.11	1.77	2.46	3.89	0.74	2.04
%SICKLE CELL INHIBITION	69.68	68.67	74.72	67.6	56.44	12.84	78.16	61.16

MORPHOLOGY OF DREPANOCYTES (PRETREATMENT & POST TREATMENT WITH

^{(T AYU-HM) USING EMMEL’S TEST
(VIEWED UNDER 45X MAGNIFICATION)}

^BLOOD^SAMPLE^{NO. 1}

^{Non treated SS Blood}

^{Treated SS Blood}^{T
AYU-HM (15ug/ml)}

^{Treated SS Blood}^{T AYU-HM(30ug/ml)}

^{Treated SS Blood}^{T AYU-HM}^(45ug/ml)

^BLOOD^SAMPLE^{NO. 2}

Non treated SS Blood

^{Treated SS Blood}^{T
AYU-HM (15ug/ml)}

^{Treated SS Blood}^{T
AYU-HM(30ug/ml)}

^{Treated SS Blood}^{T AYU-HM}^(45ug/ml)

^BLOOD^SAMPLE^{NO.
3}

^{Non
treated SS Blood}

^{Treated SS Blood}^{T
AYU-HM (15ug/ml)}

^{Treated SS Blood}^{T
AYU-HM(30ug/ml)}

^{Treated
SS Blood}^{T AYU-HM}^(45ug/ml)

^BLOOD^SAMPLE^NO.4

^{Non treated SS Blood}

^{Treated SS Blood}^{T
AYU-HM (15ug/ml)}

^{Treated SS Blood}^{T AYU-HM(30ug/ml)}

^{Treated SS Blood}^{T AYU-HM}^(45ug/ml)

^BLOOD^SAMPLE^{NO. 5}

^{Non treated SS Blood}

^{Treated SS Blood}^{T
AYU-HM (15ug/ml)}

^{Treated SS Blood}^{T AYU-HM(30ug/ml)}

^{Treated SS Blood}^{T AYU-HM}^(45ug/ml)

^BLOOD^SAMPLE^NO.6

^{Non treated SS Blood}	^{Treated SS Blood}^{T AYU-HM (15ug/ml)}	^{Treated SS Blood}^{T AYU-HM(30ug/ml)}	^{Treated SS Blood}^{T AYU-HM}^(45ug/ml)

^BLOOD^SAMPLE^NO.7
	^{Non treated SS Blood}	^{Treated SS Blood}^{T AYU-HM (15ug/ml)}	^{Treated SS Blood}^{T AYU-HM(30ug/ml)}	^{Treated SS Blood}^{T AYU-HM}^(45ug/ml)

^{Graph 1 and Graph 2
representing the % Sickle cell inhibition on Dose dependent manner and}

^{individual SS Blood sample data after
treatment with Herbomineral formulation T AYU-HM}

Graph 1 Graph 2

Dr. Atul Desai.
Dhanvantari Clinic
Ayurvedic Health Care Center
Sardar Chowk
Vyara-394650
099879031621
dratuldesai@rediffmail.com
info@vaidyarajayurveda.com
ayuhm4anaemia@indiatimes.com

• Home • About Vaidyaraj • Why Ayurveda • Role of Ayurveda
• About Dhanvantari • About Panchkarma
• Dhanvantari Charitable Trust • Sickle Cell Anaemia • T-AYU-HM
• PhotoGallery • Medical Enquiry • Mission • Contact • Finally

Check Your E - Mail

No. off Sickle cells/100 RBC’s after Emmel’s test (pretreatment to T AYU-HMTM)

MORPHOLOGY OF DREPANOCYTES (PRETREATMENT & POST TREATMENT WITH

No. off Sickle
cells/100 RBC’s
after Emmel’s
test
(pretreatment
to
T AYU-HMTM)